Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial

por Najafi, Safa, Payandeh, Mehrdad, Sadeghi, Masoud, Shafaei, Vahideh, Shojaiyan, Fateme, Abbasvandi, Fereshte
Publicado 2017